Karyopharm Restructuring Friday, September 11, 2026 0.00 Neutral

Karyopharm enters forbearance agreement

Karyopharm secured a forbearance and limited waiver from key creditors, allowing time to rectify covenant breaches and avoid default. The agreement also secures necessary waivers from holders of convertible notes.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day